Medication Use Evaluation of Dronedarone in Comparison to Amiodarone
Amiodarone is the most effective rhythm-control for atrial fibrillation, but produces serious potential side effects. Dronedarone was designed to eliminate amiodarone toxicities, but increased the risk of mortality in clinical trials. This medication use evaluation compares one year of dronedarone u...
Автори: | Adam Corey, Nita Johnston |
---|---|
Формат: | Стаття |
Мова: | English |
Опубліковано: |
University of Minnesota Libraries Publishing
2016-12-01
|
Серія: | INNOVATIONS in Pharmacy |
Предмети: | |
Онлайн доступ: | https://pubs.lib.umn.edu/index.php/innovations/article/view/480 |
Схожі ресурси
Схожі ресурси
-
Comparison of Efficacy and Safety Between Dronedarone and Amiodarone Used During the Blind Period in Patients with Atrial Fibrillation After Catheter Ablation
за авторством: Li Y, та інші
Опубліковано: (2023-12-01) -
Cost-Effectiveness of Dronedarone and Amiodarone for the Treatment of Chinese Patients With Atrial Fibrillation
за авторством: Mengran Zhang, та інші
Опубліковано: (2021-08-01) -
Dronedarone and Amiodarone Induce Dyslipidemia and Thyroid Dysfunction in Rats
за авторством: Li-Qin Jiang, та інші
Опубліковано: (2016-05-01) -
Managing atrial fibrillation in the elderly: critical appraisal of dronedarone
за авторством: Trigo P, та інші
Опубліковано: (2011-12-01) -
Dronedarone — an antiarrythmic agent with new potential for atrial fibrillation treatment
за авторством: M. Yu. Gilyarov, та інші
Опубліковано: (2010-12-01)